FDA
approval
· 2018-03-01
FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
Summary
FDA approved a supplemental application for IOPIDINE 1% (apraclidine hydrochloride ophthalmic solution) from Harrow Eye, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION)